| Guidelines for the use and interpretation of assays for monitoring autophagy DJ Klionsky, K Abdelmohsen, A Abe, MJ Abedin, H Abeliovich, ... Autophagy 12 (1), 1-222, 2016 | 13434* | 2016 |
| Molecular definitions of autophagy and related processes L Galluzzi, EH Baehrecke, A Ballabio, P Boya, JM Bravo‐San Pedro, ... The EMBO journal 36 (13), 1811-1836, 2017 | 1511 | 2017 |
| Autophagy in malignant transformation and cancer progression L Galluzzi, F Pietrocola, JM Bravo‐San Pedro, RK Amaravadi, ... The EMBO journal 34 (7), 856-880, 2015 | 1240 | 2015 |
| Acetyl coenzyme A: a central metabolite and second messenger F Pietrocola, L Galluzzi, JM Bravo-San Pedro, F Madeo, G Kroemer Cell metabolism 21 (6), 805-821, 2015 | 1150 | 2015 |
| Essential versus accessory aspects of cell death: recommendations of the NCCD 2015 L Galluzzi, BS Pedro, I Vitale, SA Aaronson, JM Abrams, D Adam, ... Cell Death & Differentiation 22 (1), 58-73, 2015 | 1144 | 2015 |
| Mitochondrial metabolism and cancer PE Porporato, N Filigheddu, JMBS Pedro, G Kroemer, L Galluzzi Cell research 28 (3), 265-280, 2018 | 978 | 2018 |
| Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles L Galluzzi, JM Bravo-San Pedro, B Levine, DR Green, G Kroemer Nature reviews Drug discovery 16 (7), 487-511, 2017 | 769 | 2017 |
| Autophagy in major human diseases DJ Klionsky, G Petroni, RK Amaravadi, EH Baehrecke, A Ballabio, P Boya, ... The EMBO journal 40 (19), e108863, 2021 | 738 | 2021 |
| Autophagy and mitophagy in cardiovascular disease JM Bravo-San Pedro, G Kroemer, L Galluzzi Circulation research 120 (11), 1812-1824, 2017 | 642 | 2017 |
| Classification of current anticancer immunotherapies. L Galluzzi, E Vacchelli, JM Bravo-San Pedro, A Buqué, L Senovilla, ... Oncotarget 5 (24), 12472-12508, 2014 | 547 | 2014 |
| Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study H Gacaferi, GS Collaborative, COVIDSurg Collaborative Anaesthesia 76 (6), 2021 | 531* | 2021 |
| Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1 E Vacchelli, Y Ma, EE Baracco, A Sistigu, DP Enot, F Pietrocola, H Yang, ... Science 350 (6263), 972-978, 2015 | 431 | 2015 |
| Molecular and translational classifications of DAMPs in immunogenic cell death AD Garg, L Galluzzi, L Apetoh, T Baert, RB Birge, BS Pedro, J Manuel, ... Frontiers in immunology 6, 169354, 2015 | 390 | 2015 |
| Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy L Galluzzi, JM Bravo-San Pedro, S Demaria, SC Formenti, G Kroemer Nature reviews Clinical oncology 14 (4), 247-258, 2017 | 298 | 2017 |
| Spermidine induces autophagy by inhibiting the acetyltransferase EP300 F Pietrocola, S Lachkar, DP Enot, M Niso-Santano, BS Pedro, V Sica, ... Cell Death & Differentiation 22 (3), 509-516, 2015 | 277 | 2015 |
| Elective cancer surgery in COVID-19–free surgical pathways during the SARS-CoV-2 pandemic: an international, multicenter, comparative cohort study JC Glasbey, D Nepogodiev, JFF Simoes, O Omar, E Li, ML Venn, PGDME, ... Journal of Clinical Oncology 39 (1), 66-78, 2021 | 263 | 2021 |
| The autophagic network and cancer MD Rybstein, JM Bravo-San Pedro, G Kroemer, L Galluzzi Nature cell biology 20 (3), 243-251, 2018 | 262 | 2018 |
| Organelle-specific initiation of cell death L Galluzzi, JM Bravo-San Pedro, G Kroemer Nature cell biology 16 (8), 728-736, 2014 | 249 | 2014 |
| Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, ... The Lancet Oncology 22 (11), 1507-1517, 2021 | 230 | 2021 |
| Mitochondrial permeability transition: new findings and persisting uncertainties V Izzo, JM Bravo-San Pedro, V Sica, G Kroemer, L Galluzzi Trends in cell biology 26 (9), 655-667, 2016 | 221 | 2016 |
